SCHEMBL7811754

SCHEMBL7811754

COc1ccc(F)c2cc3cnccc3cc12

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 1/20 0.49
MAOA P21397 2/20 0.46
HASPIN Q8TF76 4/20 0.39
CYP3A4 P08684 4/20 0.39
TRPA1 O75762 3/20 0.39
CYP17A1 P05093 1/20 0.38
NPC1 O15118 1/20 0.38
PIM1 P11309 3/20 0.38
CCNT1 O60563 1/20 0.38
CDK9 P50750 1/20 0.38
MAPT P10636 2/20 0.38
PDE10A Q9Y233 1/20 0.38
CLK1 P49759 1/20 0.37
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13686750 0.80 MAOA (0.51) MAOACYP3A4TRPA1CYP17A1CYP11B1
SCHEMBL1705716 0.80 MAOA (0.51) MAOACYP3A4TRPA1CYP17A1CYP11B1
SCHEMBL1271246 0.77 MAOA (0.59) MAOACYP3A4MAPTPDE10A
Hydrochloric Acid SCHEMBL9623496 0.76 MAOA (0.61) MAOACYP3A4PDE10A
SCHEMBL7804786 0.76 MAOA (0.48) NQO1MAOACYP3A4TRPA1CYP17A1
SCHEMBL8795800 0.76 KMT2A (0.41) CYP3A4MAPTCYP1A2CYP2D6CYP2C9
SCHEMBL27054946 0.72 CYP11B1 (0.45) MAOACYP3A4NPC1MAPTPDE10A
SCHEMBL24165355 0.71 MAOA (0.53) MAOACYP3A4PDE10ACYP11B1CYP11B2
SCHEMBL3894423 0.71 MAOA (0.53) MAOACYP3A4PDE10ACYP11B1CYP11B2
SCHEMBL31509687 0.71 CLK1 (0.46) HASPINPIM1CCNT1CDK9MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0662076-B1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY UNIV VERMONT (US) 2001-04-11 EP disclosed